Bicycle Therapeutics Plc (BCYC)
5.33
+0.19
(+3.70%)
USD |
NASDAQ |
Apr 17, 16:00
5.26
-0.07
(-1.31%)
After-Hours: 06:57
Bicycle Therapeutics SG&A Expense (Quarterly) : 20.86M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 4.191M |
| NuCana Plc | 1.472M |
| Autolus Therapeutics Plc | 35.74M |
| DBV Technologies SA | 12.79M |